Henry Mugerwa
Lubowa, C, Uganda
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Population pharmacokinetics of ritonavir-boosted atazanavir in subsequent-line treatment in African children with HIV.
Journal: Antimicrobial agents and chemotherapy
Published: July 17, 2026
Efficacy and safety of short-cycle, dolutegravir-based antiretroviral therapy in adolescents living with HIV (BREATHER Plus): a multicentre, open-label, randomised, parallel, two-arm, non-inferiority trial.
Journal: The lancet. HIV
Published: September 03, 2025
Trial design and enrolment characteristics of LATA (Long-Acting Treatment in Adolescents): A randomised, open-label, non-inferiority, 96-week trial evaluating the virological efficacy, safety, acceptability and quality-of-life of the dual long-acting injectable regimen cabotegravir/ rilpivirine compared to daily oral therapy in virologically suppressed adolescents with HIV-1 infection, aged 12 to <20 years, in Sub-Saharan Africa.
Journal: Contemporary clinical trials
Published: August 21, 2025
Kidney disease screening among adults with HIV in Uganda: a missed priority for a high-risk population.
Journal: medRxiv : the preprint server for health sciences
Published: August 20, 2025
Kidney disease screening at ART initiation among adults with HIV in Uganda: A missed priority for a high-risk population.
Journal: PLOS global public health
Published: August 06, 2025
Cabotegravir and rilpivirine for treatment of HIV infection in Africa: week 96 results from the phase 3b randomized, open-label, noninferiority CARES trial.
Journal: Nature medicine
Published: June 25, 2025
The Association of Mild Kidney Disease With Coronary Artery Disease Is Stronger for People Living With HIV.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: June 11, 2025
Implementing Wastewater-Based Epidemiology for Long-Read Metagenomic Sequencing of Antimicrobial Resistance in Kampala, Uganda.
Journal: Microorganisms
Published: April 28, 2025
Early versus deferred antiretroviral therapy initiation and long-term cardiovascular disease outcomes in people with HIV: The START study.
Journal: Open forum infectious diseases
Published: April 18, 2025
Model-based evaluation of the interaction between ritonavir-boosted atazanavir and rifampicin in Ugandan adults with HIV.
Journal: British journal of clinical pharmacology
Published: January 31, 2025
BREATHER Plus clinical trial design: A randomised non-inferiority trial evaluating the efficacy, safety and acceptability of short cycle (five days on, two days off) dolutegravir/tenofovir-based triple antiretroviral therapy (ART) compared to daily ART in virologically suppressed adolescents living with HIV aged 12 to <20 years in sub-Saharan Africa.
Journal: Contemporary clinical trials
Published: January 27, 2025
Last Updated: 09/26/2026